Aspira Pathlab & Diagnostics Ltd promoter Jay Arvind Bhanushali acquired 245 equity shares in the open market on September 28, 2026. This latest purchase brings his total holding to 7,49,507 shares, representing 7.28% of the company's total share capital.

The acquisition was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction was reported to BSE Limited on September 30, 2026. Prior to this specific purchase, Bhanushali held 7,49,262 shares, a stake that had itself increased from 7.27% earlier in September.

Transaction details

The promoter group member executed the purchase through open market transactions. The total diluted share capital of the company remains unchanged at ₹10.29 crore, divided into 1,02,93,000 equity shares of ₹10 each.

The disclosure confirms that no voting rights were acquired otherwise than by shares, and no warrants or convertible securities were involved in this specific transaction. The acquirer holds no encumbrances such as pledges or liens on these shares.

Regulatory compliance

This filing serves as a mandatory disclosure for substantial acquisitions where the change in holding is less than 5% but triggers reporting requirements for promoters. The company's registered office is located in Ghatkopar (West), Mumbai. The disclosure was submitted to BSE Limited, where the scrip is listed.

Aspira Pathlab & Diagnostics Limited reported a net profit of ₹5.13 lakh for the financial year ended March 31, 2026, marking a significant decline from the previous year's performance.

The disclosure was made during the 53rd Annual General Meeting (AGM) held on September 25, 2026, via Video Conferencing (VC) and Other Audio Visual Means (OAVM). Chairman Dr. Haseeb Ahmad Drabu informed shareholders that the current year's profit stood in stark contrast to the net profit of ₹207.26 lakh recorded in the preceding fiscal year.

Meeting proceedings and attendance

The AGM commenced at 2:10 pm and concluded at 2:30 pm. The meeting was chaired by Dr. Haseeb Ahmad Drabu, with Managing Director Nikunj Velji Mange and Director Vaibhav Odhekar in attendance. Mrs. Kiran Raghavendra Awasthi, Chairperson of the Audit and Nomination & Remuneration Committees, was also present.

Attendance details for the virtual meeting are as follows:

Mr. Manoj Jain, Partner of M/s. Sarda Soni Associates LLP, attended as the representative of the Statutory Auditors. Ms. Prajakta V. Padhye, Partner of M/s. Nilesh A. Pradhan & Co., LLP, served as the Scrutinizer and Secretarial Auditor.

Key resolutions passed

Shareholders voted on several ordinary and special business items using remote e-voting facilities provided by NSDL. The voting window opened on September 22, 2026, and closed on September 24, 2026.

The following resolutions were transacted:

1. Adoption of audited standalone financial statements for FY26.
2. Re-appointment of Nikunj V Mange as Director retiring by rotation.
3. Approval of material related party transaction with M/s. Yashraj Research Foundation.
4. Re-designation of Nikunj Velji Mange as Managing Director.
5. Regularization of Vaibhav Odhekar’s appointment as Executive Director.

What the numbers show

The financial data presented at the AGM highlights a dramatic contraction in profitability. Net profit fell to ₹5.13 lakh in FY26 from ₹207.26 lakh in FY25. This represents a decline of over 97%, indicating severe pressure on the bottom line despite the continuation of operations. The magnitude of this drop suggests either a significant increase in operational costs, a sharp reduction in revenue, or one-time exceptional charges that impacted the FY26 results, although specific drivers were not detailed in the meeting minutes.